DEPARTMENT OF HEALTH AND HUMAN SERVICES 
PUBLIC HEALTH SERVICE 
NATIONAL INSTITUTES OF HEALTH 
RECOMBINANT DNA ADVISORY COMMITTEE 
HUMAN GENE THERAPY SUBCOMMITTEE 
Minutes of Meeting 1 
July 29, 1988 
The Human Gene Therapy Subcommittee, Recombinant DNA Advisory Committee, was 
convened at 9:00 a.m. on July 29, 1988, at the National Institutes of Health, Building 31 C, 
Conference Room 6, 9000 Rockville Pike, Bethesda, Maryland 20892. Dr. LeRoy Walters 
was Chair. In accordance with Public Law 92 - 463, the meeting was open to the public. 
The following were present for all or part of the meeting. 
Subcommittee members: 
Judith Areen 
Alexander Capron 
James Childress 
William Kelley 
Robert Murray 
Paul Neiman 
The subcommittee roster is attached. 
Liaison representatives: 
Robert Cook-Deegan, Office of Technology Assessment 
Charles McCarthy, National Institutes of Health 
Charles Mackay, National Institutes of Health 
Henry Miller, Food and Drug Administration 
Ad hoc consultants: 
Robertson Parkman 
LeRoy Walters 
Anne Witherby 
William Gartland 
(Executive Secretary) 
Michael Brewer, Dun and Bradstreet Corporation 
R. Scott Mclvor, University of Minnesota 
Richard Mulligan, Whitehead Institute for Biomedical Research 
’The subcommittee is advisory to the Recombinant DNA Advisory Committee and its 
recommendations should not be considered as final or accepted. 
[180] 
Recombinant DNA Research, Volume 13 
